ArticleHepatology communications2022

Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC.

Anthony Tanoto Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.